Biosenta Inc.
ZRO
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.82M | -1.71M | -1.64M | -5.01M | -4.98M |
| Total Depreciation and Amortization | 1.90K | 2.70K | 2.20K | 1.70K | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.11M | 1.04M | 859.10K | 4.03M | 3.99M |
| Change in Net Operating Assets | 321.50K | 224.40K | 202.70K | 356.30K | 378.00K |
| Cash from Operations | -386.10K | -447.50K | -573.10K | -626.50K | -604.80K |
| Capital Expenditure | -18.50K | -18.50K | -- | -11.60K | -11.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.50K | -18.50K | -- | -11.60K | -11.60K |
| Total Debt Issued | 256.30K | 244.90K | 200.00 | 117.80K | 354.30K |
| Total Debt Repaid | -304.00K | -304.00K | -304.00K | -360.00K | -- |
| Issuance of Common Stock | 600.00K | 765.30K | 1.10M | 1.10M | 500.00K |
| Repurchase of Common Stock | -359.90K | -359.90K | -359.90K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 359.60K | 194.00K | 345.60K | -14.30K | -14.10K |
| Cash from Financing | 397.40K | 391.60K | 574.30K | 620.80K | 620.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.40K | -74.50K | 1.10K | -17.20K | 4.70K |